Prognostic impact of tumor volume in patients with stage III-IVA hypopharyngeal cancer without bulky lymph nodes treated with definitive concurrent chemoradiotherapy

Head and Neck

Volumn 31, Issue 6, 2009, Pages 709-716

  Chen, Shang Wen ^a,b,c   Yang, Shih Neng ^b,c   Liang, Ji An ^b,c   Lin, Fang Jen ^b,c   Tsai, Ming Hsui ^b,c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Chemoradiotherapy; Hypopharyngeal cancer; Prognostic factor; Tumor volume

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPOPHARYNX CANCER; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME; VOLUMETRY;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPOPHARYNGEAL NEOPLASMS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TAIWAN; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 67049144977     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21011     Document Type: Article

References (17)

1. Bahadur S, Thakar A, Mohanti BK, Lal P. Results of radiotherapy with, or without, salvage surgery versus combined surgery and radiotherapy in advanced carcinoma of the hypopharynx. J Laryngol Otol 2002;116:29-32. (Pubitemid 34048885)
2. Godballe C, Jorgensen K, Hansen O, Bastholt L. Hypopharyngeal cancer: results of treatment based on radiation therapy and salvage surgery. Larygoscope 2002;112:834-838. (Pubitemid 34477612)
3. Elias MM, Hilgers FJ, Keus RB, Gregor RT, Hart AA, Balm AJ. Carcinoma of the pyriform sinus: a retrospective analysis of treatment results over a 20-year period. Clin Otolaryngol 1995;20:249-253.
4. Chen SW, Tsai MH, Yang SN, Liang JA, Shiau AC, Lin FJ. Treatment results of hypopharyngeal cancer based on definitive radiotherapy: who is suitable for laryngeal preservation? J Laryngol Otol 2008;122:506-512.
5. Piccirillo JF. Purpose, problems, and proposals for progress in cancer staging. Arch Otolaryngol Head Neck Surg 1995;121:145-149.
6. Johnson CR, Khandelwal SR, Schmidt-Ullrich PK, et al. The influence of quantitative tumor volume measurements on local control in advanced head and neck cancer using concomitant boost accelerated superfractionated irradiation. Int J Radiat Oncol Biol Phys 1995;32:635-641.
7. Studer G, Lutolf UM, El-Bassiouni M, Rousson V, Glanzmann C. Volumetric staging is superior to TNM and AJCC staging in predicting outcome of head and neck cancer treated with IMRT. Acta Oncologica 2007;46:386-394.
8. Lee WR, Mancuso AA, Saleh EM, Mendenhall WM, Parsons JT, Million RR. Can pretreatment computed tomography findings predict local control in T3 squamous cell carcinoma of the glottic larynx treated with radiotherapy alone. Int J Radiat Oncol Biol Phys 1993;25:683-687. (Pubitemid 23099263)
9. Hermans R, den Bogaert WV, Rijnders A, Baert AL. Value of computed tomography as outcome predictor of supraglottic squamous cell carcinoma treated by definitive radiation therapy. Int J Radiat Oncol Biol Phys 1999;44:755-765. (Pubitemid 29284124)
10. Mancuso AA, Mukherji SK, Schmalfuss I, et al. Preradiotherapy computed tomography as a predictor of local control in supraglottic carcinoma. J Clin Oncol 1999;17:631-637. (Pubitemid 29075251)
11. Van den Bogaert W, van der Schueren E, Horiot JC, et al. The EORTC randomized trial on three fractions per day and misonidazole in advanced head and neck cancer: prognostic factors. Radiother Oncol 1995;35:100-106.
12. Pameijer FA, Mancuso AA, Mendenhall WM, Parsons JT, Mukherji SK. Evaluation of pretreatment computed tomography as a predictor of local control in T1/T2 pyriform sinus carcinoma treated with definitive radiotherapy. Head Neck 1998;20:159-168. (Pubitemid 28106229)
13. Plataniotis GA, Theofanopoulou ME, Kalogera-Fountzila A, Haritanti A, Ciuleanou E. Prognostic impact of tumor volumetry in patients with locally advanced head-and- neck carcinoma (non-nasopharyngeal) treated by radiotherapy alone or combined radiochemotherapy in a randomized trial. Int J Radiat Oncol Biol Phys 2004;59:1018-1026. (Pubitemid 38834294)
14. Grabenbauer GG, Steininger H, Meyer M, Fietkau R, Brunner T. Nodal CT density and total tumor volume as prognostic factors after radiation therapy of stage III/IV head and neck cancer. Radiother Oncol 1998;47:175-183. (Pubitemid 28275928)
15. Adelstein DJ, Li Y, Adams GL, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003;21:92-98.
16. Munck J-N, Cvitkovic E, Piekarski J-D, et al. Computed tomography of metastatic lymph nodes as a treatment-related prognostic factor in advanced head and neck cancer. J Natl Cancer Inst 1991;83:569-575.
17. Hoffman HT, Porter K, Karnel LH, et al. Laryngeal cancer in the United States: changes in demographics, pattern of care, and survival. Larygoscope 2006;116 (suppl):1-13. (Pubitemid 44337830)